AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2012
Aug 2, 2012
30320_dirs_2012-08-02_fca44881-6259-428e-a0e8-5a894a659208.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2012-08-01
Reporting Person: PATUSKY CHRISTOPHER (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-01 | Common Stock | M | 2000 | $27.70 | Acquired | 2000 | Direct |
| 2012-08-01 | Common Stock | S | 2000 | $54.6945 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-01 | Stock Options | $27.70 | M | 2000 | Disposed | 2016-06-26 | Common Stock (2000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1300 | Indirect |
Footnotes
F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
F3: This transaction was executed in multiple trades at prices ranging from $54.69 to $54.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.